This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_SALIVARYNAS_EXALLC for full statistics.
Malignant neoplasm of other and unspecified major salivary glands
C3_SALIVARYNAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
109 |
4. Check minimum number of eventsNone |
109 |
5. Include endpointsNone |
109 |
6. Filter based on genotype QC (FinnGen only) |
109 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified major salivary glands
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 109 | 53 | 56 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 65.01 | 64.42 | 65.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 101
- Matched controls
- 1008
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ELB30
NOMESCO Finland
Excision of submandibular gland
+∞
46.5
41
*
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
+∞
34.3
31
*
D11.70
ICD-10 Finland
Gland sublingual
+∞
33.1
30
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
293.7
23.7
23
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
28.6
23.6
32
16
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
32.1
23.0
30
13
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
21.6
20
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
+∞
21.6
20
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
24.5
21.2
30
17
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.9
20.6
69
216
8200/3-C08.0
ICD-O-3
Adenoid cystic carcinoma of submandibular gland
+∞
19.4
18
*
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
+∞
16.0
15
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
94.1
15.0
16
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
+∞
14.9
14
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.9
14.6
33
52
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
35.9
14.4
18
6
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
40.3
14.0
17
5
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
147.4
12.7
13
*
130
Kela drug reimbursment
Malignant tumour
7.6
12.1
30
53
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
73.7
11.9
13
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.7
10.8
19
18
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
10.6
10
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
33.6
9.6
12
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
109.8
9.6
10
*
C08.0
ICD-10 Finland
Malignant neoplasm: Submandibular gland
+∞
9.5
9
*
C08.01
ICD-10 Finland
Diverse adenocarcinoma of the mandibular salivary gland
+∞
9.5
9
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.7
9.2
57
259
A07AA02
ATC
nystatin; oral
8.4
8.8
19
27
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.1
8.6
24
49
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
97.8
8.5
9
*
N02AA05
ATC
oxycodone; systemic
4.6
8.5
32
92
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
19.2
8.3
12
7
WF049
NOMESCO Finland
Radiotherapy of metastasis
14.7
8.1
13
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.3
7.8
57
282
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
48.9
7.8
9
*
XW000
NOMESCO Finland
Bone marrow biopsy
13.3
7.8
13
11
Z51.5
ICD-10 Finland
Palliative care
6.8
7.7
19
33
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
7.4
7
*
8200/3-C08.9
ICD-O-3
Adenoid cystic carcinoma of major salivary gland, NOS
+∞
7.4
7
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
7.4
7
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
+∞
7.4
7
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
7.4
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
13.4
7.3
12
10
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
32.5
7.3
9
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
43.0
6.9
8
*
JN6AD
NOMESCO Finland
CT of torso and neck
43.0
6.9
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
13.5
6.8
11
9
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
6.3
6
*
C08.9
ICD-10 Finland
Malignant neoplasm: Major salivary gland, unspecified
+∞
6.3
6
*
C08.91
ICD-10 Finland
Adenocarcinoma of mixed cell type in unspecified large salivary gland
+∞
6.3
6
*
EHB00
NOMESCO Finland
Excision of lesion of palate
+∞
6.3
6
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.9
6.0
12
15
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
16
21.03
31.65
1.5
1.3
—
—
—
0
0
(4035726)
40
85
6.85
19.65
1.8
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
40
187
2.80
5.88
5.4
5.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
46
253
2.42
4.68
4.5
4.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
67
444
2.32
4.33
5.5
6.2
e9/l
0.2
0.2
0.31
62
389
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
63
423
2.16
3.75
3.9
4.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
104
2.54
3.46
11.4
8.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
10
7.39
3.42
1.7
1.1
—
—
—
0
0
(3019225) pH of Specimen
19
81
2.63
3.20
5.5
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
50
322
2.02
3.18
3.7
3.5
mmol/l
2.4
2.3
0.76
44
274
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
9
6.98
2.90
2.0
2.2
ug/l
14.4
12.4
—
6
9
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
25
3.83
2.64
1.1
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
20
96
2.33
2.63
2.0
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
26
3.68
2.54
1.1
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
62
457
1.83
2.43
7.5
7.2
mmol/l
1.2
1.2
0.09
45
385
(3002256) Pathology report gross observation
22
114
2.16
2.42
1.5
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
75
2.33
2.21
3.2
3.5
ml/min/173m2
69.6
54.6
—
5
30
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
19
3.86
2.19
1.1
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
14
4.47
2.18
1.2
1.5
—
—
—
0
0
(44790047)
5
10
5.18
2.09
1.0
1.6
—
—
—
0
0
(44806118)
5
10
5.18
2.09
1.0
1.6
—
—
—
0
0
(44790048)
5
10
5.18
2.09
1.0
1.6
—
—
—
0
0
(44790049)
5
10
5.18
2.09
1.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
20
3.67
2.09
1.1
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
15
4.17
2.07
1.2
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
56
416
1.71
2.02
6.1
6.3
mmol/l
1.2
1.2
0.97
46
373
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
87
2.13
1.92
1.5
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
48
346
1.69
1.90
3.0
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
17
3.67
1.86
1.7
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
54
2.37
1.81
1.2
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
24
3.04
1.75
1.1
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
13
3.98
1.73
1.0
4.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
100
1.96
1.65
1.7
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
84
717
1.75
1.64
12.0
7.8
u/l
82.1
77.4
0.30
75
668
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
20
3.11
1.60
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
35
242
1.66
1.58
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
15
3.44
1.54
1.2
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
52
400
1.57
1.51
11.0
9.1
inr
1.2
1.3
0.48
21
122
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
31
211
1.66
1.48
2.0
2.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
22
2.82
1.45
1.0
1.5
mg/l
5.9
13.7
—
6
22
(3020891) Body temperature
9
40
2.36
1.44
4.3
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
22
138
1.74
1.40
1.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
17
3.03
1.37
1.2
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
39
288
1.55
1.32
4.6
5.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
39
288
1.55
1.32
2.4
2.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
23
151
1.66
1.25
1.9
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
59
1.96
1.12
1.7
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
21
2.44
1.10
1.0
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
53
1.98
1.05
1.3
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
32
0.00
0.97
0.0
2.8
—
0.0
—
0
32
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
111
1.63
0.94
1.2
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
11
178
0.58
0.93
1.2
1.2
u/ml
0.4
0.8
—
6
43
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
112
1.61
0.91
1.6
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
29
2.13
0.91
3.0
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
95
880
1.62
0.88
21.5
15.2
mg/l
32.3
21.9
1.65
79
699
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
31
1.99
0.86
2.0
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
15
98
1.62
0.84
1.2
1.4
—
—
—
0
0
(4010399)
10
58
1.80
0.83
1.3
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
66
1.74
0.82
5.2
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
34
267
1.40
0.81
3.0
3.2
mg/l
2204.5
70.0
0.48
20
172
(3020682) Albumin/Creatinine [Ratio] in Urine
36
286
1.39
0.80
3.9
3.9
mg/mmol
6.3
11.2
0.73
21
177
(3037121) Protein [Mass/volume] in Urine
6
33
1.86
0.80
3.5
4.0
—
0.2
—
0
13
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.80
0.0
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
25
0.00
0.80
0.0
2.2
—
126.1
—
0
15
(3019550) Sodium [Moles/volume] in Serum or Plasma
98
921
1.63
0.77
23.3
17.6
mmol/l
139.3
139.6
0.64
93
892
(3013707) Erythrocyte sedimentation rate by Westergren method
77
693
1.38
0.76
4.5
4.4
mm/h
12.6
13.3
0.17
67
628
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
25
2.05
0.73
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
16
110
1.53
0.73
5.4
4.9
%
29.4
30.8
—
10
64
(1761868) Lipid panel - Serum or Plasma
22
289
0.70
0.73
2.5
3.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
28
1.82
0.67
2.2
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
43
502
0.76
0.65
2.8
2.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
71
1.61
0.65
1.9
2.5
—
—
—
0
0
(4034850)
5
29
1.76
0.64
23.8
10.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
8
50
1.65
0.63
3.1
3.0
mmol/l
26.1
24.5
—
8
50
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
97
1.51
0.62
3.9
3.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
34
278
1.32
0.62
2.9
3.1
mmol/l
7.8
7.1
0.25
28
223
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
63
561
1.29
0.61
3.2
3.0
u/l
79.0
52.2
0.64
56
528
(40768800) Prostate Pathology biopsy report
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
22
0.00
0.60
0.0
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.60
0.0
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
101
967
1.61
0.59
30.2
22.4
e12/l
4.4
4.5
0.79
96
935
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
35
1.75
0.59
1.3
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
96
911
1.45
0.55
20.3
13.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
100
0.58
0.54
1.5
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
35
294
1.28
0.52
2.8
3.1
ng/l
1073.1
1206.1
0.11
29
247
(3009261) Glucose [Presence] in Urine by Test strip
40
461
0.79
0.52
4.9
4.0
estimate
0.0
0.0
0.00
13
87
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
98
937
1.45
0.50
14.1
11.1
u/l
24.2
24.9
0.21
89
898
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
50
1.43
0.46
5.1
3.4
%
38.9
47.9
—
7
50
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
31
362
0.80
0.44
3.7
4.8
ug/l
1.8
2.9
0.67
25
323
(3021960) Folate [Moles/volume] in Serum or Plasma
19
236
0.76
0.44
1.6
1.6
nmol/l
19.5
22.1
0.33
14
189
(3020630) Protein [Mass/volume] in Serum or Plasma
12
88
1.41
0.42
1.9
2.5
g/l
66.4
66.1
0.06
12
78
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
124
1.34
0.41
1.7
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
44
389
1.22
0.41
16.2
11.1
e9/l
0.0
0.0
0.50
39
322
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
17
0.00
0.41
0.0
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.2
—
3.2
—
0
12
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.4
—
372.7
—
0
13
(40768443) Skin Pathology biopsy report
5
36
1.41
0.38
1.0
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
97
934
1.35
0.37
25.2
18.2
umol/l
77.5
80.9
0.87
97
934
(3021601) Nitrite [Presence] in Urine by Test strip
41
456
0.84
0.34
5.3
5.5
estimate
0.0
0.0
0.00
13
92
(3041096) Erythrocytes [Presence] in Urine by Automated
22
260
0.81
0.34
4.0
3.8
—
—
—
0
0
(3012544) pH of Venous blood
12
92
1.34
0.33
2.5
4.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
41
367
1.19
0.33
5.3
3.9
ng/l
84.6
31.6
0.62
35
270
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
80
836
0.84
0.29
3.7
4.2
mmol/l
1.3
1.3
0.10
69
750
(40761535) Cells panel - Urine sediment
9
73
1.25
0.26
5.2
3.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
9
73
1.25
0.26
5.8
2.4
g/l
8.4
9.6
—
9
66
(40758558) Short blood count panel - Blood
27
238
1.18
0.25
9.4
7.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
32
287
1.16
0.24
3.4
3.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
38
1.33
0.23
2.0
3.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
84
869
0.85
0.23
4.1
4.7
mmol/l
1.4
1.4
0.07
72
781
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
19
218
0.84
0.22
2.3
2.9
ug/l
0.6
0.7
1.62
13
148
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
4.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
321.0
—
0
6
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
48.8
—
0
6
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
38
349
1.14
0.21
3.5
3.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
13
0.00
0.21
0.0
2.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
42
451
0.89
0.20
4.7
4.0
estimate
0.0
0.0
0.00
12
91
(3036481) Cortisol [Moles/volume] in Serum or Plasma
6
79
0.75
0.16
2.5
2.2
nmol/l
437.0
361.4
—
6
70
(3000991) Gas panel - Venous blood
9
77
1.18
0.16
9.8
11.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
80
1.14
0.15
6.1
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
76
784
0.90
0.15
17.2
16.9
%
40.1
40.0
0.04
41
547
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
7
86
0.80
0.15
1.9
2.9
u/l
28.4
27.9
—
7
73
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
87
891
0.88
0.15
4.6
5.3
mmol/l
2.8
2.7
0.49
75
801
(3029937) Albumin [Presence] in Urine by Test strip
26
238
1.12
0.15
5.6
4.3
estimate
0.0
0.0
0.00
12
87
(3013512) EKG study
26
282
0.90
0.14
4.9
4.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
106
0.84
0.13
1.1
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
69
668
1.09
0.12
3.9
4.0
pmol/l
14.6
15.1
0.79
58
592
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
37
391
0.92
0.11
2.0
2.0
pmol/l
98.1
94.5
0.11
15
189
(3018418) pH of Serum or Plasma
31
292
1.09
0.10
2.9
4.7
ph
7.4
7.4
—
9
55
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
206
0.91
0.09
4.7
3.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
5
48
1.04
0.09
2.2
3.2
e6/l
0.3
0.1
—
5
48
(3037467) Urinalysis macro (dipstick) panel - Urine
60
618
0.94
0.09
4.8
4.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
55
1.10
0.09
1.8
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
27
286
0.93
0.08
2.8
4.2
%
17.5
22.3
1.41
14
135
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
86
875
0.92
0.08
3.8
4.7
mmol/l
4.7
4.5
0.52
72
796
(3028026) IgM [Mass/volume] in Serum or Plasma
7
64
1.10
0.08
2.4
1.6
g/l
0.7
1.2
—
7
55
(3033658) Prothrombin time (PT) actual/Normal
23
245
0.92
0.08
3.5
3.7
%
90.3
88.8
0.11
23
240
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
6
72
0.82
0.08
3.3
2.1
ng/l
65.5
125.5
—
6
62
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
86
846
1.08
0.07
21.0
14.5
ml/min/173m2
78.2
77.5
0.15
71
689
(3019309) Folate [Moles/volume] in Red Blood Cells
18
192
0.93
0.06
2.0
1.7
nmol/l
1372.5
1309.5
0.07
11
149
(3018095) Leukocytes [#/volume] in Urine
36
347
1.06
0.05
3.0
3.9
e6/l
20.2
58.4
1.37
28
243
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
81
821
0.95
0.04
4.5
4.8
mu/l
2.2
1.9
0.92
69
734
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
119
0.92
0.04
1.5
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
21
201
1.06
0.03
1.7
1.8
pmol/l
576.4
498.4
0.33
16
166
(3002582) Erythrocytes [#/volume] in Urine
30
308
0.96
0.02
2.8
3.3
e6/l
15.1
265.4
0.60
24
228
(3000494) Fungus identified in Specimen by Culture
12
113
1.07
0.02
1.4
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
21
217
0.96
0.01
2.4
2.1
mg/l
3.1
2.7
0.46
16
192
(36304419) Bacteria [Presence] in Urine
27
277
0.97
0.01
3.0
3.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
34
347
0.97
0.01
4.5
4.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
19
192
0.99
0.00
1.8
1.8
mg/l
2.3
1.1
0.50
13
148
(3018677) aPTT in Platelet poor plasma by Coagulation assay
16
163
0.98
0.00
1.3
1.8
s
29.9
29.8
0.01
16
156
(3044889) 12 lead EKG panel
65
653
0.99
0.00
4.0
4.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
84
841
0.99
0.00
5.9
6.3
mmol/mol
40.2
40.7
0.24
72
778
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
87
869
1.01
0.00
4.5
4.9
mmol/l
6.1
6.0
0.18
74
788
(40768797) Stomach Pathology biopsy report
13
131
0.99
0.00
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
145.3
—
0
6
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
49
1.02
0.00
1.2
1.3
—
—
—
0
0
(4281824)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
11.1
—
0
6
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
57
0.87
0.00
1.2
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
6
0.00
0.00
0.0
2.3
—
2375.0
—
0
6
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
280.8
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
0.8
—
0
9
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
16.2
6.5
mmol/l
25.1
25.0
—
5
52
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
18.9
—
0
6
(3023410) Appearance of Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
0.00
0.0
39.2
—
95.2
—
0
5
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
4.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
6
0.00
0.00
0.0
2.3
—
10.5
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
60.7
—
0
5
(3051651) Icteric interference index of Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
49
1.02
0.00
3.4
4.9
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.8
—
0.8
—
0
6
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
7.0
—
0
6
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
10.1
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
10.4
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SALIVARYNAS – Malignant neoplasm of other and unspecified major salivary glands
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).